Ledger.Open graph →
SEC Form D · filed February 12, 2025

ELIXIRGEN THERAPEUTICS, INC

Offering
$600K
Sold
$600K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Minoru Ko · BALTIMORE, MDDirectorShauna Callahan · BALTIMORE, MDDirectorJeffrey Cleland · BALTIMORE, MDDirectorThomas White · BALTIMORE, MDDirectorHiroaki Kobayashi · BALTIMORE, MDDirectorAkihiro Ko · BALTIMORE, MDExec · DirectorAkihiro Ko · BALTIMORE, MDExec · DirectorThomas White · BALTIMORE, MDDirectorJeffrey Cleland · BALTIMORE, MDDirectorHiroaki Kobayashi · BALTIMORE, MDDirectorShauna Callahan · BALTIMORE, MDDirectorMinoru Ko · BALTIMORE, MDDirectorOsvaldo Canavosio · WEST PALM BEACH, FLDirectorAndrew Laurino · New York, NYDirectorJamie Lurie · New York, NYExec · DirectorJames Roche · New York, NYDirectorJustin Lee · New York, NYDirectorJane Siebels · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗